Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FGM9T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,717
Award facts
- Contract value 100% obligated
- $12,717.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,717.18 to AmerisourceBergen Drug Corp for Wegovy 1.7 mg/0.75 mL pen injections on January 16, 2026, with an ultimate completion date of January 20, 2026. This non-set-aside award was issued under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. The IDC serves as a global pharmaceutical supply vehicle enabling delivery of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies prescription medications, generic drugs, brand-name pharmaceuticals, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order for Wegovy, a diabetes and weight management medication, represents a routine fulfillment under the company's existing pharmaceutical supply relationship with DLA, demonstrating its ongoing capability to meet federal medical supply requirements through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DR26FGM9T?
SPE2DR26FGM9T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FGM9T worth?
The government has obligated $12,717 on SPE2DR26FGM9T.
Is contract SPE2DR26FGM9T an order under another contract?
Yes. SPE2DR26FGM9T is a delivery order under SPE2DR25D1002, an indefinite delivery contract.
Was contract SPE2DR26FGM9T competed?
The extent of competition for SPE2DR26FGM9T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award